Procore (NYSE: PCOR) director to sell 1,500 shares under Rule 144
Rhea-AI Filing Summary
PROCORE TECHNOLOGIES, INC. (PCOR) is the issuer for a planned sale of restricted securities under Rule 144. Elisa A. Steele, identified as a director, has filed to sell 1,500 shares of Procore common stock, with an indicated aggregate value of $94,500.00, through Morgan Stanley Smith Barney LLC on the NYSE.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold: 1,500 shares
Aggregate sale value: $94,500.00
Acquisition date of performance shares: 02/20/2022
3 metrics
Shares to be sold
1,500 shares
Common stock proposed to be sold under Rule 144 by Elisa A. Steele
Aggregate sale value
$94,500.00
Total value listed for 1,500 common shares of Procore Technologies, Inc.
Acquisition date of performance shares
02/20/2022
Date tied to Performance Shares from which 1,500 shares are being sold
Key Terms
Rule 144, Performance Shares, Securities To Be Sold
3 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Securities To Be Sold financial
"144: Securities To Be Sold Common | 02/20/2022"
FAQ
What does the Form 144 filing mean for PROCORE TECHNOLOGIES, INC. (PCOR)?
The Form 144 filing reports that director Elisa A. Steele intends to sell 1,500 shares of PCOR common stock under Rule 144, indicating a planned disposition of previously restricted or controlled shares through a broker.
What type of PCOR securities are being sold and how were they acquired?
The securities are common stock of PROCORE TECHNOLOGIES, INC., identified as Performance Shares acquired from the Issuer on 02/20/2022. A total of 1,500 shares from this grant are planned for sale.
AI-generated analysis. How Rhea-AI works. Not financial advice.